Pharmakonzern · Vereinigtes Königreich
AstraZeneca
Ein Konzern aus 50 Unternehmen: 937 Arzneimittel, verteilt auf 12 Länder.
Konzernstruktur
50 Unternehmen, verteilt auf 19 Länder
Deine Seite wird geladen …
Deine Seite wird geladen …
Pharmakonzern · Vereinigtes Königreich
Ein Konzern aus 50 Unternehmen: 937 Arzneimittel, verteilt auf 12 Länder.
50 Unternehmen, verteilt auf 19 Länder
Ein kostenloses Konto für die Prognia-Apps: Ward zum Lernen, Osler für klinische Antworten mit ihren Quellen und das Netzwerk, um deine Kolleginnen und Kollegen zu finden.
Prognia stellt Konzerne aus den Namen zusammen, die Behörden veröffentlichen, und aus Verknüpfungen zwischen Unternehmen; sie sind keine offizielle Konzernstruktur.
Alle Arzneimittel aller Unternehmen im Konzern, aktuelle zuerst.
1–25 von 937
| Arzneimittel | Wirkstoff | Land | Status | Zulassung |
|---|---|---|---|---|
| AIRSUPRA0.09mg base/inh; 0.08mg/inh · Aerosol, metered | Salbutamol, Budesonide | Vereinigte Staaten | Im Handel | 2023 |
| AQUASOL A25,000usp units | 50,000usp units · Capsule | Vitamin a | Vereinigte Staaten | Nicht im Handel | |
| ARDECTO | Dapagliflozina propanodiol, Saxagliptin | Brasilien | Zugelassen | 2021 |
| ARIMIDEX1 mg · Tablet | Anastrozole | Kanada | Im Handel | 1996 |
| ARIMIDEX | Anastrozole | Brasilien | Zugelassen | 1996 |
| ARIMIDEX TABLET 1 mg1 mg · Tablet, film coated | Anastrozole | Singapur | Zugelassen | 1997 |
| BAXFENDY1mg | 2mg · Tablet | Baxdrostat | Vereinigte Staaten | Im Handel | 2026 |
| BEVESPI AEROSPHERE0.0048mg/inh; 0.0090mg/inh · Aerosol, metered | Formoterol, Glycopyrronium | Vereinigte Staaten | Im Handel | 2016 |
| Bevespi Aerosphere | Glycopyrronium, Formoterol | EU (EMA) | Zugelassen | 2018 |
| BEVESPI AEROSPHERESospensione pressurizzata per inalazione | Glycopyrronium, Formoterol | Italien | Zugelassen | |
| Bevespi Aerosphere 7,2 micrograms/5,0 micrograms, Aërosol, suspensieAërosol, oplossing | Formoterol, Glycopyrroniumbromide | Niederlande | Zugelassen | 2018 |
| BEVESPI AEROSPHERE® | Brometo glicopirrônio, Formoterol | Brasilien | Zugelassen | 2020 |
| BEYFORTUS100mg | 50mg · Injectable | Nirsevimab | Vereinigte Staaten | Im Handel | 2023 |
| BREZTRI AEROSPHERE0.16mg/inh; 0.0048mg/inh; 0.009mg/inh | 0.16mg/inh; 0.0048mg/inh; 0.018mg/inh · Aerosol, metered | Budesonide, Formoterol, Glycopyrronium | Vereinigte Staaten | Im Handel | 2020 |
| BREZTRI AEROSPHERE | Budesonide, Brometo glicopirrônio, Formoterol | Brasilien | Zugelassen | 2024 |
| BREZTRI AEROSPHERE160 mcg / act + 5 mcg / act + 7.2 mcg / act · Aerosol (Metered-Dose) | Budesonide, Formoterol, Glycopyrronium | Kanada | Im Handel | 2021 |
| BREZTRI AEROSPHERE PRESSURISED INHALATION SUSPENSION 160 MCG/7.2 MCG/5 MCG per actuation160 μg/actuation + 5.0 μg/actuation + 7.2 μg/actuation · Aerosol, metered | Budesonide, Formoterol, Glycopyrronium | Singapur | Zugelassen | 2023 |
| Bricanyl 250 Turbuhaler, inhalatiepoeder 250 microgram/dosisInhalatiepoeder | Terbutaline | Niederlande | Zugelassen | 1993 |
| Bricanyl 500 Turbuhaler, inhalatiepoeder 500 microgram/dosisInhalatiepoeder | Terbutaline | Niederlande | Zugelassen | 1988 |
| BRICANYL TURBUHALER0.5 mg / dose · Powder | Terbutaline | Kanada | Im Handel | 1990 |
| BRILINTA60 mg · Tablet | Ticagrelor | Kanada | Im Handel | 2016 |
| BRILINTA90 mg · Tablet | Ticagrelor | Kanada | Im Handel | 2011 |
| BRILINTA60mg | 90mg · Tablet | Ticagrelor | Vereinigte Staaten | Im Handel | 2011 |
| BRILINTA | Ticagrelor | Brasilien | Zugelassen | 2010 |
| BRILINTA TABLET 60 MG60 mg · Tablet, film coated | Ticagrelor | Singapur | Zugelassen | 2017 |
Wo es Zulassungen hält oder Arzneimittel herstellt, und wie viele davon aktuell sind.
| Land | Arzneimittel | Aktuell | Früher | Unternehmen |
|---|---|---|---|---|
| Kanada | 153 | 73 | 80 | UnternehmenAlle Arzneimittel |
| Saudi-Arabien | 139 | 139 | 0 | UnternehmenAlle Arzneimittel |
| Brasilien | 135 | 51 | 84 | UnternehmenAlle Arzneimittel |
| Spanien | 110 | 93 | 17 | UnternehmenAlle Arzneimittel |
| Vereinigte Staaten | 99 | 97 | 2 | UnternehmenAlle Arzneimittel |
| Niederlande | 77 | 77 | 0 | UnternehmenAlle Arzneimittel |
| Singapur | 62 | 62 | 0 | UnternehmenAlle Arzneimittel |
| Rumänien | 54 | 0 | 54 | UnternehmenAlle Arzneimittel |
| Europäische Union (EMA) | 52 | 38 | 14 | UnternehmenAlle Arzneimittel |
| Italien | 45 | 45 | 0 | UnternehmenAlle Arzneimittel |
| Kroatien | 9 | 9 | 0 | UnternehmenAlle Arzneimittel |
| Argentinien | 2 | 0 | 2 | UnternehmenAlle Arzneimittel |
Auch registriert in: Frankreich, Serbien, Vereinigtes Königreich
Die ATC-Gruppen, zu denen die meisten seiner Arzneimittel gehören, größte zuerst.
Die Wirkstoffe in den meisten seiner Arzneimittel.
Wie die Register den Namen schreiben, normalisiert: ohne Rechtsform, Akzente und Großbuchstaben.
Von Prognia aus den unten genannten öffentlichen Arzneimittel- und Unternehmensregistern zusammengestellt. Logos werden nicht verwendet.
Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.
Source: European Medicines Agency (EPAR data).
Lizenz: EMA reuse policy (source acknowledgement required)
Fuente de la información: AEMPS (CIMA).
Lizenz: AEMPS open data reuse with attribution
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Lizenz: Public domain (U.S. Government work)
Source: BDPM (ANSM, HAS, UNCAM).
Lizenz: Licence Ouverte v1.0
Ministerio de Salud / ANMAT, historical VNM changes, Actualizaciones del Vademecun Nacional de Medicamentos (VNM) - julio 2018, https://datos.salud.gob.ar/dataset/vademecun-nacional-de-medicamentos-vnm, CC BY 4.0, acquired 2026-10-09; structured factual adaptation.
Lizenz: Creative Commons Attribution
ANVISA / CMED, consumer price table; embedded source date 2026-07-21 and retrieval date
Lizenz: Other (Public Domain)
Anvisa published factual open-data CSV https://dados.anvisa.gov.br/dados/CONSULTAS/PRODUTOS/TA_CONSULTA_MEDICAMENTOS.CSV, HTTP version Mon, 12 Oct 2026 11:45:25 GMT; acquired 12 October 2026; original source states and timestamps retained.
Lizenz: Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Lizenz: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Lizenz: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Lizenz: Open Government Licence Canada
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Lizenz: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Lizenz: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
BDPM / ANSM, HAS and UNCAM; original URLs and each update date retained
Lizenz: BDPM exact Licence Ouverte v1.0 (October 2011)
INSEE (www.insee.fr), via DINUM API Recherche d’entreprises; include original record update date and retrieval date
Lizenz: Licence Ouverte / Open Licence
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 1 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:47.757811+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Lizenz: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 2 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:48.423930+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Lizenz: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; October 2026 register, published 7 October 2026; https://assets.publishing.service.gov.uk/media/6ac660fdec9d3aba1e0139d9/MS_Register_-_October_2026.csv; acquired 2026-10-13T22:59:02.704630+00:00; CSV-to-role/site projection is an adaptation under Open Government Licence v3.0.
Lizenz: Open Government Licence v3.0; Crown copyright MHRA factual register
GLEIF; exact source URLs/locators, version status and retrieval dates. Normalized by Prognia; no official endorsement.
Lizenz: CC0
HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.
Lizenz: Otvorena dozvola RH
Contains Irish Public Sector Data licensed under Creative Commons Attribution 4.0 International (CC BY 4.0), Companies Registration Office; original dataset/API URL and company number, exact locator/source version and retrieval date; selected field normalization by Prognia. https://creativecommons.org/licenses/by/4.0/
Lizenz: Creative Commons Attribution
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_A_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:41 GMT; acquired 2026-10-13T17:21:06.055244+00:00; native fields retained, source identifier and role projections are adaptations.
Lizenz: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_H_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:40 GMT; acquired 2026-10-13T17:21:06.034935+00:00; native fields retained, source identifier and role projections are adaptations.
Lizenz: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.
Lizenz: CC BY 4.0; AIFA published open-data catalog
Ministero della Salute, Italy; https://www.dati.salute.gov.it/it/dataset/distributori-di-farmaci/; original CSV snapshot 15 October 2026, acquired 2026-10-15T13:26:43.659718+00:00; adapted factual fields under IODL2. Coordinates: © OpenStreetMap contributors, separate rights gate.
Lizenz: Italian Open Data Licence v2.0, exact dataset-catalog assignment; coordinate fields separately attributed to OpenStreetMap
Ministero della Salute, Distributori di farmaci, source file13Oct2026. https://www.dati.salute.gov.it/it/dataset/distributori-di-farmaci/; IODL2.0 https://www.dati.gov.it/content/italian-open-data-license-v20. Original URLs/locators and retrieval timestamps; selected/normalized by Prognia; no government endorsement.
Lizenz: Italian Open Data Licence
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Lizenz: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
Contains data under the Norwegian licence for Open Government data (NLOD) distributed by Brønnøysundregistrene. https://data.norge.no/nlod/en/2.0; original API URLs, retrieval dates and locators. Selected and normalized by Prognia; fractional JSON numbers preserved as labelled exact decimal strings.
Lizenz: Norwegian Licence for Open Government Data
Ministerul Sănătății, Catalogul public naţional al preţurilor, 18 iunie 2021, downloaded 2026-10-08 from data.gov.ro; CC BY 4.0; structured factual adaptation, code whitespace trimmed only where explicitly recorded.
Lizenz: Creative Commons Attribution 4.0 International (CC BY 4.0)
ALIMS, Registar humanih lekova, source 08.10.2026 02:00, downloaded 2026-10-08, https://data.gov.rs/sr/datasets/lekovi-za-upotrebu-u-khumanoj-meditsini/; structured factual adaptation; Serbian Open Data Licence.
Lizenz: Serbian Open Data Licence (sodl)
Saudi Food and Drug Authority (SFDA), foreign human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.
Lizenz: Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only
Contains information from ACRA Information on Corporate Entities, accessed on 8 October 2026 through Data.gov.sg, under Singapore Open Data Licence version 1.0: https://data.gov.sg/open-data-licence. Structured selection and normalisation by Prognia; original UEN, field and retrieval date retained.
Lizenz: Singapore Open Data Licence
Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence
Lizenz: Singapore Open Data Licence
FDA Purple Book, September 2026 release; acquired 2026-10-10T15:29:54.330165+00:00; exact source fields retained with source-key projections.
Lizenz: FDA-created structured factual administrative metadata; public-domain policy with third-party exceptions
Fehler melden oder Entfernung beantragenKorrekturen vom Unternehmen selbst sind willkommen.
Halten Sie die Arzneimittel von AstraZeneca auf Prognia korrekt, sehen Sie, wie Fachleute sie nutzen, und beantworten Sie ihre Fragen. Ein 20-minütiges Gespräch, auf Englisch.
Gespräch buchenBekannte Pharmakonzerne, jeweils mit allen Unternehmen.
Nach der Zahl ihrer Arzneimittel geordnet.